We are live on ! Find out more
AMAM

Ambrx Biopharma Inc

Delisted

AMAM was delisted on the 6th of March, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$15.8M -$152K -29,666 -0.8%
BlackRock
2
BlackRock
New York
$11.7M -$92.1K -18,000 -0.6%
CAM
3
Cormorant Asset Management
Massachusetts
$10.2M
AG
4
Artal Group
Luxembourg
$8.87M
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$8.35M +$530K +103,591 +5%
FI
6
Fosun International
China
$7.96M
SCM
7
Suvretta Capital Management
New York
$6.15M +$2.22M +434,097 +41%
OCA
8
Octagon Capital Advisors
New York
$616K -$959K -187,468 -56%
Millennium Management
9
Millennium Management
New York
$430K +$30.7K +6,010 +6%
Norges Bank
10
Norges Bank
Norway
$288K
Renaissance Technologies
11
Renaissance Technologies
New York
$93K +$55.2K +10,800 +92%
Tudor Investment Corp
12
Tudor Investment Corp
Connecticut
$83K
Morgan Stanley
13
Morgan Stanley
New York
$12K
Bank of America
14
Bank of America
North Carolina
$1K +$563 +110 +84%
CCM
15
CAAS Capital Management
New York
-$118K -13,068 Closed
MIFH
16
Migdal Insurance & Financial Holdings
Israel
-$1K -124 Closed